Literature DB >> 11355029

Quality-of-life assessment of morbidly obese patients who have undergone a Lap-Band operation: 2-year follow-up study. Is the MOS SF-36 a useful instrument to measure quality of life in morbidly obese patients?

R Hörchner1, M W Tuinebreijer, P H Kelder.   

Abstract

BACKGROUND: Quality of life (QoL) was tested in a 2-year postoperative study using the Medical Outcome Study Short Form 36 (MOS SF-36) to assess preoperative and 1 and 2 year postoperative QoL among one group of female patients (group 1, n = 42) and a 2 year postoperative QoL study in a second group of female patients (group 2, n = 9) who underwent a stomach reduction operation involving open surgical placement of a Lap-Band during the year 1997.
METHODS: The QoL of 42 patients (group 1) was assessed at most 20 hours before surgery and 1 and 2 years (12 and 24 months) postoperatively using a randomized pre-test/post-test design. The QoL of 9 patients (group 2) was assessed 2 years (24 months) postoperatively using a randomized post-test design only. The results were compared with the standardized Dutch norm datascale. Statistical data were analyzed with SPSS versions 10.0.
RESULTS: The placement of a Lap-Band in group 1 resulted in a significant reduction in Body Mass Index (BMI) in the first and second-year follow-up. Mean BMI declined significantly from 40.7 kg/m2 preoperatively to 33.1 kg/m2 at the 1-year follow-up, to 31.3 kg/m2 at 2-year follow-up. In group 2 BMI also declined significantly from 43.0 kg/m2 preoperatively to 34.2 kg/m2 at 1-year follow-up to 32.1 kg/m2 at the 2-year follow-up. Compared to the MOS SF-36 standardized Dutch norm data, a significant improvement in the QoL was seen on the effect variable bodily pain, mental health and general health perceptions in group 1. Although the bodily pain, general health and mental health perceptions increased significantly 2 years postoperatively (group 1) compared with the Dutch standardized norm data, the preoperative general health and mental health perceptions of morbidly obese patients were, like all other preoperative effect variables, not significantly different from the scores on the Dutch standardized norm scale.
CONCLUSION: Although other authors found that QoL improves after surgical-induced weight loss, showing significant improvements on patients' perception of their health status, these findings were not confirmed in the present study. The findings show only a significant difference in bodily pain, general health and mental health perception before and after surgical intervention and preoperatively in group 1 compared to the Dutch standardized norm data. Because of small sample size (n = 9), no significant results were found in group 2 compared to the Dutch Standardized norm data. Based on earlier and present findings, further study is recommended to ascertain whether the MOS SF-36 is valid in morbidly obese patients and whether the response set has an influence on QoL studies of these patients.

Entities:  

Mesh:

Year:  2001        PMID: 11355029     DOI: 10.1381/096089201321577901

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  13 in total

1.  Changes in quality of life after balloon treatment followed by gastric banding in severely obese patients--the use of two different quality of life questionnaires.

Authors:  Sonja J E Rutten; Suzan de Goederen-van der Meij; Robert G J M Pierik; Elisabeth M H Mathus-Vliegen
Journal:  Obes Surg       Date:  2008-10-22       Impact factor: 4.129

2.  SAGES guideline for clinical application of laparoscopic bariatric surgery.

Authors: 
Journal:  Surg Endosc       Date:  2008-10       Impact factor: 4.584

3.  Health-related quality of life following vertical banded gastroplasty.

Authors:  Gerbrand C M van Hout; Frederiek A M Fortuin; Aline J M Pelle; Marieke E Blokland-Koomen; Guus L van Heck
Journal:  Surg Endosc       Date:  2008-03-25       Impact factor: 4.584

Review 4.  Quality of life and bariatric surgery: a systematic review of short- and long-term results and comparison with community norms.

Authors:  L C H Raaijmakers; S Pouwels; S E M Thomassen; S W Nienhuijs
Journal:  Eur J Clin Nutr       Date:  2016-11-02       Impact factor: 4.016

Review 5.  Analysis of health-related quality-of-life instruments measuring the impact of bariatric surgery: systematic review of the instruments used and their content validity.

Authors:  Raed Tayyem; Abdulmajid Ali; John Atkinson; Colin R Martin
Journal:  Patient       Date:  2011       Impact factor: 3.883

Review 6.  A review of the relationships between extreme obesity, quality of life, and sexual function.

Authors:  David B Sarwer; Megan Lavery; Jacqueline C Spitzer
Journal:  Obes Surg       Date:  2012-04       Impact factor: 4.129

7.  Observations regarding 'quality of life' and 'comfort with food' after bariatric surgery: comparison between laparoscopic adjustable gastric banding and sleeve gastrectomy.

Authors:  Paul Brunault; David Jacobi; Julie Léger; Céline Bourbao-Tournois; Noël Huten; Vincent Camus; Nicolas Ballon; Charles Couet
Journal:  Obes Surg       Date:  2011-08       Impact factor: 4.129

8.  Analyzing the Psychometric Properties of the Short Form-36 Quality of Life Questionnaire in Patients with Obesity.

Authors:  Rashed Al Amer; Khalid Al Khalifa; Safeyah Ali Alajlan; Ahmed Al Ansari
Journal:  Obes Surg       Date:  2018-08       Impact factor: 4.129

9.  The effect of bariatric surgery on patient HRQOL and sexual health during a 1-year postoperative period.

Authors:  Vasileios Efthymiou; Thomas Hyphantis; Katerina Karaivazoglou; Philippos Gourzis; Theodoros K Alexandrides; Fotios Kalfarentzos; Konstantinos Assimakopoulos
Journal:  Obes Surg       Date:  2015-02       Impact factor: 4.129

10.  The health-related quality of life of obese persons seeking or not seeking surgical or non-surgical treatment: a meta-analysis.

Authors:  Annemieke M A van Nunen; Eveline J M Wouters; Ad J J M Vingerhoets; Joop J Hox; Rinie Geenen
Journal:  Obes Surg       Date:  2007-10       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.